Autoantibody response against a novel testicular antigen protein highly expressed in testis (PHET) in SSc patients

Autoimmunity Reviews

Volumn 6, Issue 4, 2007, Pages 228-231

  Yasuoka, Hidekata ^a   Kuwana, Masataka ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Protein highly expressed in testis (PHET); Systemic sclerosis

Indexed keywords

ANTIGEN; AUTOANTIBODY; DNA; MESSENGER RNA; PROTEIN HIGHLY EXPRESSED IN TESTIS; SPERM ASSOCIATED ANTIGEN 9; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; CELL STRAIN HEPG2; DNA LIBRARY; FIBROSIS; GENE CLUSTER; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; IMMUNOPATHOGENESIS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOANTIBODIES; AUTOANTIGENS; DNA, COMPLEMENTARY; FEMALE; FIBROBLASTS; GENE LIBRARY; HUMANS; MALE; SCLERODERMA, SYSTEMIC; SKIN; TESTIS;

EID: 33847027591     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.08.006     Document Type: Review

References (15)

1. Silver R.M., Medsger Jr. T.A., and Bolster M.B. Systemic sclerosis and scleroderma variants: clinical aspects. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis and allied conditions (2005), Lippincott Williams and Wilkins, Philadelphia 1633-1680
2. LeRoy E.C. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 51 (1992) 286-288
3. Korn J.H. Pathogenesis of systemic sclerosis. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis and allied conditions (2005), Lippincott Williams and Wilkins, Philadelphia 1621-1632
4. Kuwana M., Kaburaki J., Okano Y., Tojo T., and Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37 (1994) 75-83
5. Okano Y. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 22 (1996) 709-735
6. Yasuoka H., Ihn H., Medsger Jr. T.A., Hirakata M., Kawakami Y., Ikeda Y., et al. A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies. J Immunol 171 (2003) 6883-6890
7. Barker C.F., and Billingham R.E. Immunologically privileged sites. Adv Immunol 25 (1977) 1-54
8. Bart J., Groen H.J.M., van der Graaf W.T.A., Hollema H., Hendrikse N.H., Vaalburg W., et al. An oncological view on the blood-testis barrier. Lancet Oncol 3 (2002) 357-363
9. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., and Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature 377 (1995) 630-632
10. Fiszer D., and Kurpisz M. Major histocompatibility complex expression on human, male germ cells: a review. Am J Reprod Immunol 40 (1998) 172-176
11. Suri A. Cancer-testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 6 (2006) 379-389
12. Kawakami Y. New cancer therapy by immunomanipulation: development of immunotherapy for human melanoma as a model system. Cornea 19 (2000) S2-S6
13. Jagadish N., Rana R., Mishra D., Kumar M., and Suri A. Sperm associated antigen 9 (SPAG9): a new member of c-Jun NH2-terminal kinase (JNK) interacting protein exclusively expressed in testis. Keio J Med 54 (2005) 66-71
14. Lee C.M., Onesime D., Reddy C.D., Dhanasekaran N., and Reddy E.P. JLP: a scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A 99 (2002) 14189-14194
15. Kelkar N., Standen S.L., and Davis R.J. Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol 25 (2005) 2733-2743